Omicron をターゲットとする新しい二重株ブースター ワクチンが秋に発売予定

Omicron をターゲットとする新しい二重株ブースター ワクチンが秋に発売予定
UK first country to approve use of so-called bivalent vaccine as officials prepare for winter and expected rise in Covid cases

A newly-approved COVID vaccine that offers protection against the original 武漢 virus and the オミクロン variant is to be rolled out in the coming weeks as part of the UK’s autumn booster programme.

The UK is the first country in the world to approve the use of the so-called bivalent vaccine, manufactured by モダン and known as “Spikevax bivalent Original/Omicron”, 高齢者では 18 オーバー.

The jab, which triggers a strong immune response against both Omicron (BA.1) とオリジナル 2020 ウイルス, will be offered to millions of over-50s ahead of winter — as recommended by the Joint Committee on Vaccination and Immunisation (JCVI).

A number of additional vaccines are set to be used for the autumn programme, including the original Pfizer and Moderna shots, パンデミックの間、何千万人もの英国人に安全に投与されてきました, as well as the Novavax jab.

ウェイ・シェン・リム教授, chair of Covid-19 immunisation on the JCVI, 前記: “All of the available booster vaccines offer very good protection against severe illness from Covid-19. As more vaccines continue to be developed and approved, the JCVI will consider the benefits of including them in the UK programme.

“It is important that everyone who is eligible takes up a booster this autumn, whichever vaccine is on offer. This will increase your protection against being severely ill from Covid-19 as we move into winter.”

The Spikevax vaccine was given the green light earlier on Monday by the UK medicines regulator (MHRA). その決定は、ブースターがオミクロンと武漢で出現した元のウイルスの両方に対して「強力な免疫反応」を引き起こしたことを示した臨床試験データに基づいていました。 2019, と言いました.

六月に, モデルナは、試験データは、4回目の投与として与えられたときにそれを示したと述べた, バリアントに適応したショットは、Omicron に対して 8 倍のウイルス中和抗体を生成しました.

The MHRA also cited an exploratory analysis in which the vaccine was found to generate a good immune response against the currently dominant Omicron offshoots BA.4 and BA.5. 新しい処方では重大な安全上の懸念は確認されませんでした, 代理店が追加.

今年の夏の初め, healths official announced that all people aged 50 and over are to be offered a Covid-19 booster and flu jab.

だいたい 29 million Britons will be eligible, with over-75s and the most vulnerable expected to start receiving their doses from September, 英国健康安全保障局によると.

Under guidance outlined by the JCVI, all frontline health and social care workers will be offered another booster jab, as will those aged 5 に 49 who are deemed clinically at-risk, 妊婦を含む, and household contacts of people with compromised immune systems.

For people aged 75 オーバー, this will be their fifth Covid jab, having already received a spring booster. For the over-50s, it will be the fourth dose.

The JCVI has said it will review the use of any additional vaccines which are redesigned to target multiple forms of the Covid virus.

NHS England is set to confirm details on how and when eligible people can access the autumn booster vaccine in due course.

メアリーラムゼイ博士, head of immunisation at UKHSA, 前記: “Although cases of Covid-19 are relatively low at present, we are expecting to see the virus circulating more widely during the winter months.

“The booster is being offered to those at higher risk of severe illness and by taking up the booster vaccine this autumn, you will increase your protection ahead of the winter months, when respiratory viruses are typically at their peak.”